Skip to main content Skip to journal navigation menu Skip to site footer
contact@ukscip.com
Review

Upper Airway Treatable Traits in Obstructive Sleep Apnea: Bridging Otolaryngology and Respiratory Medicine

Norifumi Kudeken ORCID
    Received: 1 October 2026; Revised: 20 October 2026; Accepted: 2 November 2026; Published: 9 November 2026

    Abstract

    Obstructive sleep apnea (OSA) is a heterogeneous disorder in which recurrent upper-airway obstruction reflects variable combinations of anatomical vulnerability and non-anatomical physiology. A treatable-traits framework may help move management beyond the apnea-hypopnea index by linking clinically relevant, modifiable characteristics to specific interventions. This narrative review focuses on upper-airway traits at the interface of otolaryngology, respiratory medicine, and sleep medicine. Nasal obstruction, tonsillar hypertrophy, palatal and lateral pharyngeal collapse, tongue-base obstruction, craniofacial restriction, epiglottic collapse, and position-dependent obstruction may be actionable, but the strength of evidence supporting treatment selection varies by trait. Drug-induced sleep endoscopy (DISE) can characterize dynamic collapse and may change management in selected patients, although visualization of a collapse pattern is not equivalent to validated prediction of treatment response. Positive airway pressure remains a cornerstone of therapy, while oral appliance therapy, positional therapy, site-directed surgery, maxillomandibular advancement, hypoglossal nerve stimulation, nasal treatment, and weight management may be appropriate for selected phenotypes. Anatomical findings should be integrated with physiological endotypes, comorbidity, treatment burden, and patient preference. We propose an evidence-informed, iterative pathway that distinguishes direct therapeutic targets from enabling traits and emerging treatment-selection markers, emphasizes selective rather than routine use of DISE, and incorporates clinical and objective reassessment tailored to treatment and clinical context. The goal of precision OSA care is not maximal phenotyping, but clinically useful phenotyping that changes management while acknowledging uncertainty.

    Keywords

    References

    1. 1. Eckert, D.J.; White, D.P.; Jordan, A.S.; Malhotra, A.; Wellman, A. Defining phenotypic causes of obstructive sleep apnea: identification of novel therapeutic targets. Am J Respir Crit Care Med 2013, 188(8), 996–1004. https://doi.org/10.1164/rccm.201303-0448OC
    2. 2. Tolbert, T.M.; Schmickl, C.N.; Gell, L.K.; et al. Research priorities for translating endophenotyping of adult obstructive sleep apnea to the clinic: an official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2025, 211(9), 1562–1583. https://doi.org/10.1164/rccm.202507-1574ST
    3. 3. Agusti, A.; Bel, E.; Thomas, M.; et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016, 47(2), 410–419. https://doi.org/10.1183/13993003.01359-2015
    4. 4. Kezirian, E.J.; Hohenhorst, W.; de Vries, N. Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol 2011, 268(8), 1233–1236. https://doi.org/10.1007/s00405-011-1633-8
    5. 5. Sleep Respiratory Diseases Working Committee; Respiratory Physician Branch; Chinese Medical Doctor Association. Expert consensus on the application of drug-induced sleep endoscopy in the diagnosis and treatment of obstructive sleep apnea (2025 edition). Zhonghua Yi Xue Za Zhi 2025, 105(38), 3384–3393. https://doi.org/10.3760/cma.j.cn112137-20250331-00773
    6. 6. Correa, E.J.; Conti, D.M.; Moreno-Luna, R.; Sanchez-Gomez, S.; O'Connor Reina, C. Role of nasal surgery in adult obstructive sleep apnea: a systematic review. Sleep Sci 2024, 17(3), e310-e321. https://doi.org/10.1055/s-0044-1782527
    7. 7. Camacho, M.; Li, D.; Kawai, M.; et al. Tonsillectomy for adult obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope 2016, 126(9), 2176–2186. https://doi.org/10.1002/lary.25931
    8. 8. MacKay, S.; Carney, A.S.; Catcheside, P.G.; et al. Effect of multilevel upper airway surgery vs medical management on the apnea-hypopnea index and patient-reported daytime sleepiness among patients with moderate or severe obstructive sleep apnea: the SAMS randomized clinical trial. JAMA 2020, 324(12), 1168–1179. https://doi.org/10.1001/jama.2020.14265
    9. 9. Ramar, K.; Dort, L.C.; Katz, S.G.; et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med 2015, 11(7), 773–827. https://doi.org/10.5664/jcsm.4858
    10. 10. Walker, A.; Kassir, M.F.; Sama, V.; Nguyen, S.A.; Abdelwahab, M. Maxillomandibular advancement safety and effectiveness in obstructive sleep apnea: systematic review and meta-analysis. Otolaryngol Head Neck Surg 2025, 172(4), 1142–1154. https://doi.org/10.1002/ohn.1114
    11. 11. Al-Bayyati, H.H.R.; Hassing, G.J.; van der Hoeve, E.P.; Koppendraaier, L.; de Ruiter, M.H.T. Patient-reported outcomes with focus on health-related quality of life in patients with obstructive sleep apnea treated with maxillomandibular advancement surgery: a systematic review and meta-analysis. J Oral Maxillofac Surg 2025, 83(5), 543–557. https://doi.org/10.1016/j.joms.2025.01.010
    12. 12. Torre, C.; Camacho, M.; Liu, S.Y.C.; Huon, L.K.; Capasso, R. Epiglottis collapse in adult obstructive sleep apnea: a systematic review. Laryngoscope 2016, 126(2), 515–523. https://doi.org/10.1002/lary.25589
    13. 13. Gao, Y.; Zhu, S.; Li, W.; Lai, Y. Comparative efficacy of sleep positional therapy, oral appliance therapy, and CPAP in obstructive sleep apnea: a meta-analysis of mean changes in key outcomes. Front Med (Lausanne) 2025, 12, 1517274. https://doi.org/10.3389/fmed.2025.1517274
    14. 14. Lisan, Q.; Baudouin, R.; Lechien, J.R.; Hans, S.; Blumen, M. Is drug-induced sleep endoscopy associated with better outcomes after soft tissue surgery for sleep apnea? A systematic review and meta-analysis. Clin Otolaryngol 2023, 48(2), 122–129. https://doi.org/10.1111/coa.14008
    15. 15. Di Bari, M.; Colombo, G.; Giombi, F.; Leone, F.; Bianchi, A.; Colombo, S.; Salamanca, F.; Cerasuolo, M. The effect of drug-induced sleep endoscopy on surgical outcomes for obstructive sleep apnea: a systematic review. Sleep Breath 2024, 28(2), 859–867. https://doi.org/10.1007/s11325-023-02931-z
    16. 16. Li, C.; Wang, C.; Zhang, Y.; et al. Loop gain in obstructive sleep apnea: from physiological endotype to clinical translation. Nat Sci Sleep 2026, 18, 616733. https://doi.org/10.2147/NSS.S616733
    17. 17. Malhotra, A.; Grunstein, R.R.; Fietze, I.; et al.; SURMOUNT-OSA Investigators. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med 2024, 391, 1193–1205. https://doi.org/10.1056/NEJMoa2404881
    18. 18. Kapur, V.K.; Auckley, D.H.; Chowdhuri, S.; et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017, 13(3), 479–504. https://doi.org/10.5664/jcsm.6506
    19. 19. Caples, S.M.; Anderson, W.M.; Calero, K.; Howell, M.; Hashmi, S.D. Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement. J Clin Sleep Med 2021, 17(6), 1287–1293. https://doi.org/10.5664/jcsm.9240
    20. 20. Veugen, C.C.A.F.M.; Kant, E.; Kelder, J.C.; Schipper, A.; Stokroos, R.J.; Copper, M.P. The predictive value of mandibular advancement maneuvers during drug-induced sleep endoscopy for treatment success of oral appliance treatment in obstructive sleep apnea: a prospective study. J Clin Sleep Med 2024, 20(3), 353–361. https://doi.org/10.5664/jcsm.10866
    21. 21. Kent, D.; Stanley, J.; Aurora, R.N.; et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021, 17(12), 2499–2505. https://doi.org/10.5664/jcsm.9592
    22. 22. Strollo, P.J., Jr.; Soose, R.J.; Maurer, J.T.; et al.; STAR Trial Group. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014, 370(2), 139–149. https://doi.org/10.1056/NEJMoa1308659
    23. 23. Inspire Upper Airway Stimulation - P130008/S090. U.S. Food and Drug Administration. Available online: https://www.fda.gov/medical-devices/recently-approved-devices/inspire-upper-airway-stimulation-p130008s090 (accessed on 21 September 2026).
    24. 24. Bonsignore, M.R.; Mazzuca, E.; Baiamonte, P.; et al. REM sleep obstructive sleep apnoea. Eur Respir Rev 2024, 33(171), 230166. https://doi.org/10.1183/16000617.0166-2023
    25. 25. Pengo, M.F.; Martinez Garcia, M.A.; Vitiello, M.V.; Gozal, D. OSA in the aging population: diagnostic and therapeutic considerations. Sleep Med Rev 2026, 86, 102247. https://doi.org/10.1016/j.smrv.2026.102247
    26. 26. Sunwoo, B.Y.; Raphelson, J.R.; Malhotra, A. Chronic obstructive pulmonary disease and obstructive sleep apnea overlap: who to treat and how? Expert Rev Respir Med 2024, 18(7), 527–537. https://doi.org/10.1080/17476348.2024.2384036
    27. 27. Nguyen, B.H.M.; Murphy, P.B.; Yee, B.J. Chronic obstructive pulmonary disease and obstructive sleep apnea overlap syndrome: an update on the epidemiology, pathophysiology, and management. Sleep Med Clin 2024, 19(3), 405–417. https://doi.org/10.1016/j.jsmc.2024.04.003
    28. 28. Fabozzi, A.; Bouloukaki, I.; Bonini, M.; Schiza, S.E.; Palange, P. Asthma-OSA overlap syndrome: a distinct endophenotype? Respir Med 2025, 248, 108344. https://doi.org/10.1016/j.rmed.2025.108344
    29. 29. Hack, S.; Alsleibi, S.; Shemesh, S.; Nakache, G. AI meets sleep surgery: assessing drug-induced sleep endoscopy interpretation with a large language model. Sleep 2026, 49(7), zsaf338. https://doi.org/10.1093/sleep/zsaf338
    30. 30. BaHammam, A.S. Phenotyping obstructive sleep apnea: a pathway to precision medicine. Sleep Breath 2026, 30(2), 125. https://doi.org/10.1007/s11325-026-03672-5
    ×